Stockholders’ Equity (Details) - USD ($)	1 Months Ended	3 Months Ended		12 Months Ended
	Feb. 29, 2024	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2022	Feb. 07, 2024	Dec. 31, 2023
Stockholders’ Equity [Line Items]
Preferred stock shares authorized (in Shares)		10,000,000				10,000,000
Common stock shares authorized (in Shares)		300,000,000				300,000,000
Common stock, par value (in Dollars per share)		$ 0.0001				$ 0.0001
Shares of restricted common stock issued (in Shares)				338,121
Total recourse notes				$ 164,116
Subscription receivable		$ 165,629				$ 169,616
Restricted stock award liability		154,630				$ 158,617
Vesting of restricted common stock		$ 41,303	$ 71,362
Weighted-average remaining term		1 year 18 days				1 year 3 months 18 days
Placement agent warrants were exercised (in Shares)	125,000
Purchase of shares (in Shares)		63,479
Stock-based compensation expense		$ 4,255,432	$ 93,943
Warrant [Member]
Stockholders’ Equity [Line Items]
Common stock warrants exercised (in Shares)	125,000
Common stock warrants exercised proceeds	$ 5,832
Private placement offering for gross proceeds	$ 5,832
Restricted Stock [Member]
Stockholders’ Equity [Line Items]
Weighted-average remaining term		7 years 8 months 26 days
Magna Warrant [Member]
Stockholders’ Equity [Line Items]
Purchase of shares (in Shares)					2,145,000
Exercise price per share (in Dollars per share)					$ 0.01
Warrants		$ 8,566,184
Stock-based compensation expense		4,182,543
Restricted Stock [Member]
Stockholders’ Equity [Line Items]
Subscription receivable		165,629		165,719
Restricted stock award liability		$ 154,630		$ 162,747
Common Stock [Member]
Stockholders’ Equity [Line Items]
Repurchased restricted stock awards (in Shares)		0	(238,625)